Thoracic Surgery Devices Market Size & Growth Forecast 2026–2035, By Segments (End-use, Surgery Type, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Thoracic Surgery Devices Market size stood at USD 778.95 Million in 2025 and is predicted to grow at a 6.5% CAGR from 2026 to 2035, surpassing USD 1.46 Billion by 2035. The industry revenue for 2026 is calculated at USD 823.12 million.

• Base Year Value (2025): USD 778.95 Million
• CAGR (2026-2035): 6.5%
• Forecast Year Value (2035): USD 1.46 Billion
• Historical Data Period: 2022-2025
• Largest Region: North America
• Forecast Period: 2026-2035

Thoracic Surgery Devices Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America accounted for 41.20% of the market in 2025, supported by advanced surgical infrastructure, widespread minimally invasive procedures, and strong adoption of device-intensive thoracic interventions.
  • Asia Pacific is projected to grow at a 7.35% CAGR as hospitals modernize, surgical access expands, and providers increasingly adopt advanced thoracic procedures and specialized devices.

• Segment Momentum:

  • Hospitals held a 48.65% share in 2025 because they provide advanced operating infrastructure, multidisciplinary surgical teams, and critical postoperative care required for complex thoracic procedures.
  • Wedge resection is the fastest-growing surgery type as demand increases for tissue-sparing procedures that preserve lung function while treating localized abnormalities through less invasive approaches.

• Market Expansion Drivers:

  • Aging population increasing incidence of lung and cardiac thoracic conditions requiring surgery.
  • Adoption of minimally invasive and robotic-assisted thoracic surgical techniques.
  • Expanding outpatient surgical procedures increasing demand for precision thoracic instruments.

• Leading Market Participants:

  Top players in the thoracic surgery devices market include Medtronic plc (Ireland), Intuitive Surgical, Inc. (United States), Teleflex Incorporated (United States), Richard Wolf GmbH (Germany), LivaNova PLC (United Kingdom), Medela Holding AG (Switzerland), Sklar Surgical Instruments (United States), Cardio Medical GmbH (Germany), Grena Ltd. (United Kingdom).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 778.95 Million
  • Projected Market Size: USD 1.46 Billion by 2035
  • Growth Forecasts: 6.5% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Hospitals (End-use) | Lobectomy (Surgery Type) | Forceps (Product)
  • Emerging Opportunity Segment: Ambulatory Surgical Centers (End-use) | Wedge Resection (Surgery Type) | Staplers (Product)

Market Growth Drivers and Industry Trends

Aging population increasing incidence of lung and cardiac thoracic conditions requiring surgery

As older patient populations expand, hospitals are seeing a higher volume of thoracic cases linked to lung cancer, chronic obstructive pulmonary disease complications, valvular disorders, and other age-associated cardiothoracic conditions that more often progress to surgical intervention. This patient mix is influencing procurement in the thoracic surgery devices market toward stapling systems, energy devices, retractors, suturing tools, and access instruments that can support complex procedures in patients with reduced physiological reserve. The effect is not limited to procedure counts; aging-related comorbidities also push surgeons and care teams to favor devices that improve procedural control, reduce operative trauma, and help shorten recovery time, reinforcing demand for advanced thoracic surgical platforms and consumables.

Adoption of minimally invasive and robotic-assisted thoracic surgical techniques

The shift from open thoracotomy toward video-assisted and robotic-assisted procedures is reshaping device requirements in the thoracic surgery devices market by changing how surgeons access, visualize, and manipulate tissue in confined chest anatomy. Facilities investing in minimally invasive thoracic programs need specialized trocars, endoscopic staplers, articulated instruments, camera systems, and compatible energy devices that can deliver precision through smaller incisions. This transition also alters replacement cycles and purchasing decisions, since clinical teams increasingly prioritize devices that improve dexterity, enable more consistent dissection and sealing, and fit integrated robotic workflows, aiding market expansion through both capital equipment uptake and recurring instrument demand.

Expanding outpatient surgical procedures increasing demand for precision thoracic instruments

As selected thoracic procedures move into outpatient and short-stay settings, providers are placing greater emphasis on instruments that support procedural efficiency, reliable tissue handling, and predictable recovery pathways. In the thoracic surgery devices market, this is increasing market adoption for precision stapling, sealing, and visualization tools that help reduce operating time, minimize complications, and streamline post-operative discharge. Ambulatory-focused care models also tend to standardize device selection around products that are easy to use, reproducible across surgical teams, and aligned with tighter workflow and turnover requirements, driving market development for high-performance thoracic instrument portfolios.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Increasing thoracic surgeries and procedural demand	2.50%	Short term (≤ 2 yrs)	North America, Europe (spillover: Asia Pacific)	High	Fast
Technological advancement in thoracic surgery devices	2.00%	Medium term (2–5 yrs)	Europe, Asia Pacific (spillover: North America)	Medium	Moderate
Expansion of surgical centers and minimally invasive interventions	2.00%	Long term (5+ yrs)	North America, Europe (spillover: Asia Pacific)	Medium	Slow
Aging population increasing incidence of lung and cardiac thoracic conditions requiring surgery	2.10%	Moderate	North America, Europe	High	Near Term
Adoption of minimally invasive and robotic-assisted thoracic surgical techniques	1.90%	High	North America, Asia Pacific	High	Mid Term
Expanding outpatient surgical procedures increasing demand for precision thoracic instruments	1.40%	Moderate	Asia Pacific, Europe	Medium	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the leading position in 2025, accounting for a 41.20% share of the thoracic surgery devices market. This leadership is supported by the region’s established thoracic surgical care infrastructure, broad access to advanced operating room technologies, and the routine adoption of device-intensive procedures across major hospitals and specialty centers. Demand is further reinforced by consistent use of minimally invasive and robot-assisted approaches in thoracic interventions, where device performance, procedural efficiency, and clinical workflow integration directly shape purchasing activity.

Asia Pacific is projected to register a 7.35% CAGR over the forecast period in the thoracic surgery devices market, driven by expanding access to surgical treatment and the gradual modernization of hospital capabilities across key healthcare systems. Growth is accelerating as more providers adopt advanced thoracic procedures, supported by rising procedural volumes, improving surgeon training, and stronger availability of specialized devices in urban and developing care networks. In practice, this creates a broader installed base for thoracic interventions and increases procurement of devices tied to both conventional and minimally invasive surgical techniques.

Key Country Insights

United States

Minimally Invasive Advancement

U.S. hospitals continue adopting thoracic surgery devices that support minimally invasive and robotic-assisted procedures. Healthcare providers prioritize technologies that improve surgical precision, reduce recovery times, and enhance outcomes in complex thoracic interventions.

Japan

Advanced Clinical Integration

Japan strengthens use of thoracic surgery devices through integration with advanced imaging, minimally invasive techniques, and specialized surgical workflows. Healthcare providers focus on improving procedural accuracy while supporting better patient recovery.

South Korea

Robotic Surgery Adoption

South Korea increasingly incorporates thoracic surgery devices into robotic-assisted and video-assisted surgical procedures. Hospitals invest in advanced instrumentation that enhances precision, workflow efficiency, and treatment quality for thoracic disease management.

Germany

Surgical Precision Focus

Germany emphasizes thoracic surgery devices engineered for precision, reliability, and integration with advanced operating room technologies. Clinical adoption centers on improving procedural efficiency and supporting specialized thoracic and cardiothoracic surgical practices.

France

Specialized Procedure Support

France prioritizes thoracic surgery devices that meet the needs of specialized surgical centers managing complex pulmonary and thoracic conditions. Clinical purchasing decisions emphasize dependable performance, ergonomic design, and compatibility with minimally invasive techniques.

Italy

Hospital Technology Enhancement

Italy expands investment in thoracic surgery devices that improve surgical efficiency and support minimally invasive treatment approaches. Italian healthcare providers value versatile instruments that integrate effectively into modern operating rooms and specialized thoracic care pathways.

Segment Leadership and Growth Trends

  End-use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)

Hospitals held the strongest position in the thoracic surgery devices market in 2025, accounting for a 48.65% share. Their dominance is sustained by the concentration of complex thoracic procedures in hospital settings, where access to advanced operating infrastructure, critical care support, and multidisciplinary surgical teams remains essential. This is particularly important for procedures that carry higher perioperative risk or require immediate postoperative monitoring, reinforcing hospitals as the primary end-use environment for thoracic surgery devices market demand.

Ambulatory Surgical Centers are emerging as the fastest-growing end-use segment in the thoracic surgery devices market as procedural workflows increasingly shift toward settings that can support efficient, lower-acuity interventions. Their growth is being propelled by the rising suitability of less invasive thoracic techniques for outpatient or short-stay care, which makes these facilities an attractive alternative to hospitals for selected cases. Compared with traditional inpatient settings, Ambulatory Surgical Centers gain momentum from their ability to align with evolving provider preferences for streamlined scheduling, faster patient turnover, and controlled procedural costs.

Surgery Type Segment Analysis: Lobectomy (Largest Segment) vs Wedge Resection (Fastest-Growing Segment)

By surgery type, lobectomy represented the largest portion of the thoracic surgery devices market in 2025, with a 45.79% share. Its leadership reflects the procedure’s established role in thoracic surgical practice, particularly where full lobe removal is required to manage serious pulmonary conditions. Because lobectomy typically involves extensive tissue handling, vessel sealing, stapling, and dissection, it drives consistent utilization of thoracic surgery devices, helping the segment maintain its leading share.

Wedge resection is the fastest-growing surgery type in the thoracic surgery devices market, aided by the increasing preference for tissue-sparing approaches in appropriately selected patients. Its momentum relative to more extensive resections comes from growing procedural demand for targeted intervention that can preserve lung function while still addressing localized abnormalities. As clinical practice places greater emphasis on less invasive management pathways where feasible, wedge resection is seeing stronger uptake and creating faster growth for the devices used in these procedures.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
End-use	Hospitals, Ambulatory Surgical Centers, Others	Hospitals	Ambulatory Surgical Centers
Surgery Type	Lobectomy, Wedge Resection, Pneumonectomy, Others	Lobectomy	Wedge Resection
Product	Clamps, Forceps, Graspers, Staplers, Scissors, Spreaders, Needle Holders, Others	Forceps	Staplers

Competitive Landscape and Market Positioning

Major players in the thoracic surgery devices market:

1. Medtronic plc (Ireland)

2. Intuitive Surgical Inc. (United States)

3. Teleflex Incorporated (United States)

4. Richard Wolf GmbH (Germany)

5. LivaNova PLC (United Kingdom)

6. Medela Holding AG (Switzerland)

7. Sklar Surgical Instruments (United States)

8. Cardio Medical GmbH (Germany)

9. Grena Ltd. (United Kingdom)

Continuous innovation in minimally invasive procedures is advancing the thoracic surgery devices market, with research focused on robotic-assisted systems, enhanced visualization, and precision surgical instruments. These technological developments are improving surgical efficiency, patient safety, and postoperative recovery outcomes.

Industry Development/News

Company Name	Date	Key Development
Prana Thoracic, Inc.	Mar-23	Prana Thoracic, Inc. secured USD 3 million in Series A funding to advance development of thoracic surgical technologies. The financing supports R&D activities aimed at improving surgical device innovation and accelerating commercialization efforts within minimally invasive thoracic procedures, strengthening the company’s position in the emerging surgical devices landscape.
Johnson & Johnson	Jun-25	Johnson & Johnson launched the ETHICON 4000 Stapler in the U.S., designed to address complex tissue handling and improve staple line integrity. The device aims to reduce surgical leaks and bleeding risks across procedures, strengthening the company’s advanced surgical portfolio in thoracic and minimally invasive surgery applications.
Intuitive Surgical	Apr-25	Intuitive Surgical received U.S. FDA approval for the SP SureForm 45 stapler compatible with the da Vinci SP system. The device enhances wristed articulation and procedural precision in minimally invasive thoracic, colorectal, and urologic surgeries, reinforcing the company’s robotic-assisted surgery ecosystem and expanding its advanced stapling capabilities.
Olympus Corporation	Mar-25	Olympus Corporation launched an AI-powered clinical decision support tool through a partnership with Ziosoft. The solution enhances surgical planning and clinical decision-making capabilities, strengthening Olympus’s digital transformation strategy and expanding its role in AI-enabled medical technologies for improved surgical outcomes.
Johnson & Johnson	Jul-24	Johnson & Johnson introduced the ECHELON 3000 Stapler, a digitally enabled surgical device designed to improve precision, articulation range, and staple line control. The system enhances laparoscopic surgical efficiency and strengthens the company’s minimally invasive surgery portfolio with advanced digital and ergonomic capabilities.